Cardiovascular Update For the Clinician: A Symposium by Valentin Fuster

Join Valentin Fuster, MD, PhD, MACC, and an esteemed panel of leading experts for an in-depth symposium highlighting the most important advances shaping cardiovascular medicine in 2026. Designed to bridge groundbreaking research and everyday clinical practice, this course translates the latest scientific discoveries into practical, evidence-based strategies to improve patient outcomes.

Across two focused sessions, faculty will present "The Five Advances" in ten critical areas of cardiovascular care — from early detection of coronary atherosclerosis and management of acute coronary syndromes to the latest therapies in heart failure, rhythm disorders, and valvular disease. Participants will gain up-to-date insights into evolving diagnostics, innovative treatments, and emerging challenges across the spectrum of cardiovascular disease.

This comprehensive update offers clinicians an unparalleled opportunity to stay at the forefront of cardiovascular science and apply the latest advancements directly to patient care.

• Cardiovascular Update For the Clinician I: A Symposium by Valentin Fuster (Session 108)
• Cardiovascular Update For the Clinician II: A Symposium by Valentin Fuster (Session 109)

Pharmacology Program

Deepen your understanding of today's most innovative and impactful cardiovascular therapies in this year's Pharmacology Program, designed to help clinicians translate the latest evidence into practice.

In the first session, experts will explore the interconnected nature of cardiovascular, kidney and metabolic disease. Learn how emerging therapies such as GLP-1 receptor agonists and MRAs deliver multisystem benefits — and gain practical guidance on identifying CKM patients, implementing treatment strategies, and improving access to care.

Then, in the second session, faculty will highlight cutting-edge management approaches for TTR cardiac amyloidosis and iron deficiency in heart failure. Through case-based discussions and real-world insights, participants will discover how to combine therapies effectively, navigate access challenges, and deliver the most advanced treatments to their patients.

Whether you're seeking to update your pharmacologic knowledge or optimize therapy selection in complex cardiovascular conditions, this course provides the latest data, practical pearls, and actionable strategies to elevate patient care.

• Blues and Breakthroughs: A Big Easy Guide to the Newer Pillars of CKM Syndromes (Session 259)
• From Evidence to Implementation of Heart Failure Therapeutics in Cardiac Amyloidosis and Iron Deficiency (Session 274)